BioCentury | May 26, 2020
Deals

With trio of COVID deals, Merck takes a page from its Ebola strategy

...had raised at least $75.5 million in venture financings from investors such as Wellington Partners, Ventech...
BioCentury | Sep 20, 2019
Finance

Themis preps first clinical test of oncolytic viral approach with €40M round

...first-time backer Adjuvant Capital and existing investors Global Health Investment Fund, aws Gründerfonds, Omnes Capital, Ventech...
BioCentury | Dec 1, 2016
Financial News

Themis Bioscience completes venture financing

...$10.6 million) in a series B round led by existing investor Wellington Partners. Existing investors Ventech...
BioCentury | May 16, 2015
Company News

Circassia bids for respiratory plays Aerocrine, Prosonix

...corticosteroid, a long-acting beta agonist (LABA) and a long-acting muscarinic antagonist (LAMA). Its shareholders include Ventech...
BioCentury | May 11, 2015
Financial News

Themis Bioscience completes venture financing

...Infectious Date completed: 2015-05-05 Type: Venture financing Raised: EUR7 million ($7.8 million) Investors: Wellington Partners; Ventech...
BioCentury | Feb 14, 2015
Company News

Intrexon acquires mucosal therapeutics play ActoGeniX

...from investors including Saffelberg Investments; Biovest; Gimv; Biotech Fund Flanders; Baekeland Fund; VIB; LSP; Aescap; Ventech...
BioCentury | Sep 1, 2014
Finance

Exiting Covagen

...that we enable them to continue to be productive," Dillon said. MP Healthcare Venture Management, Ventech...
BioCentury | Dec 16, 2013
Financial News

Covagen completes venture financing

...Ascent Biomedical Ventures; Novartis Venture Funds; Edmond de Rothschild Investment Partners; Seroba Kernel Life Sciences; Ventech...
BioCentury | Dec 10, 2013
Financial News

Covagen secures $47.1 million in series B

...with existing investors Novartis Venture Fund; Edmond de Rothschild Investment Partners; Seroba Kernel Life Sciences; Ventech...
BioCentury | Jul 30, 2012
Finance

Funxional in form

...are evaluating whether they want to fund development of GAEL. Funxional's other VC investors include Ventech...
Items per page:
1 - 10 of 58
BioCentury | May 26, 2020
Deals

With trio of COVID deals, Merck takes a page from its Ebola strategy

...had raised at least $75.5 million in venture financings from investors such as Wellington Partners, Ventech...
BioCentury | Sep 20, 2019
Finance

Themis preps first clinical test of oncolytic viral approach with €40M round

...first-time backer Adjuvant Capital and existing investors Global Health Investment Fund, aws Gründerfonds, Omnes Capital, Ventech...
BioCentury | Dec 1, 2016
Financial News

Themis Bioscience completes venture financing

...$10.6 million) in a series B round led by existing investor Wellington Partners. Existing investors Ventech...
BioCentury | May 16, 2015
Company News

Circassia bids for respiratory plays Aerocrine, Prosonix

...corticosteroid, a long-acting beta agonist (LABA) and a long-acting muscarinic antagonist (LAMA). Its shareholders include Ventech...
BioCentury | May 11, 2015
Financial News

Themis Bioscience completes venture financing

...Infectious Date completed: 2015-05-05 Type: Venture financing Raised: EUR7 million ($7.8 million) Investors: Wellington Partners; Ventech...
BioCentury | Feb 14, 2015
Company News

Intrexon acquires mucosal therapeutics play ActoGeniX

...from investors including Saffelberg Investments; Biovest; Gimv; Biotech Fund Flanders; Baekeland Fund; VIB; LSP; Aescap; Ventech...
BioCentury | Sep 1, 2014
Finance

Exiting Covagen

...that we enable them to continue to be productive," Dillon said. MP Healthcare Venture Management, Ventech...
BioCentury | Dec 16, 2013
Financial News

Covagen completes venture financing

...Ascent Biomedical Ventures; Novartis Venture Funds; Edmond de Rothschild Investment Partners; Seroba Kernel Life Sciences; Ventech...
BioCentury | Dec 10, 2013
Financial News

Covagen secures $47.1 million in series B

...with existing investors Novartis Venture Fund; Edmond de Rothschild Investment Partners; Seroba Kernel Life Sciences; Ventech...
BioCentury | Jul 30, 2012
Finance

Funxional in form

...are evaluating whether they want to fund development of GAEL. Funxional's other VC investors include Ventech...
Items per page:
1 - 10 of 58